Neurochemistry Changes Associated with Mutations in Familial Parkinson's Disease
Keywords: AIF; ATM; ATP13A2; Akt1; Akt2; Bcl-2; Cytochrome C; DA; DJ 1; Depolymerization; Dictyostelium discoidum; Dopamine; Drosophila; E2F; ERM; FeCl2; G2385R; GTPase; Granzyme M; HSPs; HtrA2; LRRK2; Lewy bodies; MPTP; Microglial; Mutations; NF-B; Neurochemistry; OHDA; PI3K; PINK-1; PINK1; PTM; Parkin; Parkinson's disease (PD); RNAi; ROS; RanBP2; SIAH-1; SNpc; Synuclein; TRAP1; UCH-L1 (PARK5); UPS; XIAP; apoptosis; exocytosis; homeostasis; leucine-rich repeat kinase 2; lysosomal; mitochondrial dysfunction; neurites; neurotoxicity; pathophysiology; phosphorylation; protein; protein aggregation; rotenone; synucleinases; toxicity; toxins; ubiquitin
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.